NPI: 1043274921 · RICHMOND, VA 23223 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/17/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/17/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 36,250 | $366K |
| 2019 | 33,144 | $506K |
| 2020 | 25,377 | $440K |
| 2021 | 25,622 | $362K |
| 2022 | 25,051 | $603K |
| 2023 | 20,081 | $731K |
| 2024 | 5,501 | $286K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 51,789 | 3,332 | $3.13M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 56,393 | 2,569 | $97K |
| A4657 | Syringe, with or without needle, each | 11,040 | 2,450 | $31K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 256 | 144 | $14K |
| J1756 | Injection, iron sucrose, 1 mg | 12,459 | 2,308 | $11K |
| J1270 | Injection, doxercalciferol, 1 mcg | 27,457 | 1,741 | $6K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 1,203 | 356 | $517.74 |
| 90674 | 148 | 94 | $482.40 | |
| 83970 | 2,198 | 1,281 | $480.09 | |
| G0008 | Administration of influenza virus vaccine | 146 | 100 | $268.06 |
| 82728 | 826 | 523 | $149.22 | |
| 83540 | 990 | 611 | $86.49 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 198 | 95 | $52.79 |
| 83550 | 946 | 584 | $35.99 | |
| 82108 | 573 | 367 | $32.47 | |
| 85041 | 2,205 | 1,340 | $24.11 | |
| 85048 | 2,182 | 1,321 | $20.88 | |
| 0011A | 17 | 12 | $16.94 |